Journal article icon

Journal article

Quadrivalent meningococcal conjugate vaccines

Abstract:
Neisseria meningitidis is an important cause of bacterial meningitis and septicaemia with most disease caused by meningococci bearing serogroups A, B, C, Y and W-135 polysaccharides. Monovalent serogroup C conjugate vaccines have become established in the immunisation programmes in many countries and the first quadrivalent meningococcal vaccine, containing the polysaccharides from 4 of the serogroups A, C, Y and W-135 meningococci conjugated to a protein carrier was licensed in the US in 2005. This vaccine and others in development offer the potential to broaden population protection against meningococcal disease.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

  • Cite

  • Print

Access Document

Publisher copy:
10.1016/j.vaccine.2009.05.003

Authors

More by this author
Institution:
"Mater Dei Hospital, Tal-Qroqq, Malta"
Department:
Department of Paediatrics
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Tropical Medicine
Research group:
Oxford Vaccine Group
Role:
Author
More by this author
Institution:
"National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA"
Department:
Meningitis and Special Pathogens Branch,Division of Bacterial and Mycotic Diseases
Role:
Author

Publisher:
Elsevier
Journal:
Vaccine More from this journal
Volume:
27
Issue:
Supplement 2
Pages:
B30-B41
Publication date:
2009-06-01
DOI:
ISSN:
0264-410X

Language:
English
Keywords:
Subjects:
UUID:
uuid:709e10f4-9bda-49b6-8b29-dc0f74b089c8
Local pid:
ora:3245
Deposit date:
2010-01-20

Terms of use

Views and Downloads





If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP